A-80426, 4-tetrahydronaphthalen-1-yl-methyl]-N-methylamine) represents
the first example of a new structural class of agents combining poten
t alpha-2 antagonist activity with equivalent 5-HT uptake inhibitory a
ctivity. This profile of combined activities may have utility in the t
reatment of depression.